# Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

> **NCT03775213** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 322 (actual)

## Conditions studied

- Ductal Carcinoma in Situ

## Interventions

- **BEHAVIORAL:** Decision Support Tool with Active Monitoring
- **BEHAVIORAL:** Decision Support Tool without Active Monitoring

## Key facts

- **NCT ID:** NCT03775213
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-12
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2023-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03775213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03775213, "Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03775213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*